服务电话(移):17319309550
The VEGF Inhibitor, CBO-P11 controls the biological activity of VEGF. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
DMSO: 5 mg/mL;water: soluble
Supplied as a trifluoroacetate salt.
Zilberberg, L., et al. 2003. J. Biol. Chem.278, 35564.
A macrocyclic, 17-amino acid peptide derived from residues 79-93 of vascular endothelial growth factor (VEGF) that mediates the binding of VEGF to its receptor, VEGFR-2. Blocks the binding of VEGF₁₆₅ to its receptors (IC₅₀ = 70 nM for VEGFR-1, 1.3 µM for VEGFR-2) and exhibits anti-angiogenic properties. Also reported to block other VEGF-mediated cellular functions such as proliferation (IC₅₀ = 5.8 µM), migration (IC₅₀ = 8.2 µM), and activation of MAP kinases. Also reported to exhibit anti-angiogenic properties in vivo using chick embryo and nude mouse tumor models of human intracranial and syngeneic glioma.
Supplied as a trifluoroacetate salt.
Packaged under inert gas
Target IC₅₀: 700 nM for VEGFR1, 1.3 µM for VEGFR2
cyclic(D-Phe-Pro-Gln-Ile-Met-Arg-Ile-Lys-Pro-His-Gln-Gly-Gln-His-Ile-Gly-Glu)
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity: Carcinogenic / Teratogenic (D)
好评度 | 商品满意度 | 服务满意度 | 发货满意度 |
"676496-1MG,VEGF Inhibitor, CBO-P11"商品可能已被商家删除,您可查看其他相似商品!
相似产品推荐